Precision Oncology

The completion of the Human Genome Project has revolutionized both cancer research and cancer treatment, and instantly catapulted cancer research forward into the 21st century. From the very beginning, the Netherlands Cancer Institute has been in the very forefront of biomarker-guided precision oncology.

It is our mission to optimize precision diagnostics and treatment, to ultimately make this treatment type available to the majority of patients. We do this by way of close collaborations between the lab, the clinic and the pharmacy, investments in new technologies and research models ranging from AI to organoids, innovative clinical trials, and international collaboration.